PUBLIC CONTRACT · 2025

Aquisição de Doxorrubicina 2 mg/ml sol inj fr 100 ml IV Ivesical, Etoposido 20 mg/ml sol inj fr 5 ml IV, Gemcitabina 40 mg/ml sol inj fr 25 ML IV, Peginterferão Alfa-2A 0.18 mg/0.5 ml sol inj ser 0.5 ml SC e Vincristina 1 mg/ml sol inj fr 2 ml IV

Contract value
€2,496.00
Signed on
17 February 2025
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11316210

PUBLISHED DESCRIPTION

Doxorrubicina 2 mg/ml sol inj fr 100 ml IV Ivesical, Etoposido 20 mg/ml sol inj fr 5 ml IV, Gemcitabina 40 mg/ml sol inj fr 25 ML IV, Peginterferão Alfa-2A 0.18 mg/0.5 ml sol inj ser 0.5 ml SC e Vincr

Parties involved

Place of performance
Portugal, Lisboa, Lisboa
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491

Values and timeline

Contract price
€2,496.00
Procedure base price
€24,000.69
Total effective price
Not reported on Portal BASE
Publication date
29 March 2025
Award date
3 February 2025
Signing date
17 February 2025
Performance period
90 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7434801

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts